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Diagnosing Infection in Febrile Granulocytopenic Patients With 
Indium-111-Labeled Human Immunoglobulin G
By W im J.G. Oyen, Roland A.M J. Claessens, John M.M. Raemaekers, Ben E. de Pauw, Jos W.M. van der Meer,
and Frans H.M. Corstens
Purpose: Delineation of focal infection is a major prob­
lem in the m anagem ent of febrile granulocytopenic p a ­
tients. The utility of ind ium -111—labeled human nonspe­
cific immunoglobulin G ( ln -1 11—IgG), a newly developed 
radiopharmaceutical for imaging focal inflammation, was 
reported in patients with adequate WBC counts. In the 
present study, we investigated whether ln -1 11—IgG scin­
tigraphy could be used to locate infection in granulocyto­
penic patients.
Materials and Methods: Granulocytopenic rats with 
focal infection were imaged after In -111—IgG injection. 
Thereafter, ln -1 11—IgG scintigraphy was performed in 20 
granulocytopenic patients. Images were obtained 4, 24, 
and 48 hours after injection of 75 mBq In -111—IgG. 
Scintigraphic findings were compared with clinical, roent­
genologic, and ultrasonographic methods and culture 
results.
Results: In the animal model high ln -1 11—IgG accumu-
FEV ER POSES A major diagnostic and therapeutic problem in patients with severe granulocytopenia. 
Approximately 70% of these patients experience one or 
more febrile episodes.' In granulocytopenic patients, 
clinical signs of infection are often scarce, and in 50% to 
70% of the patients, no cause of the fever can be 
detected .2 '' Some authors'’ estimate that 20% to 40% of 
febrile patients do not have an infection and that the 
fever is of paraneoplastic origin or caused by drugs. 
When a focus is found, the identification of the causative 
microorganism and installation of adequate therapy are 
facilitated.
Recently, the utility of indium-111-labeled human 
nonspecific polyclonal immunoglobulin G ( ln -1 11—IgG) 
scintigraphy to detect focal infection has been re­
ported .78 All patients in these studies had either normal 
or elevated WBC counts. In this study, we addressed the 
issue of whether In -111—IgG scintigraphy could be 
helpful in delineating infection in febrile granulocytope­
nic patients. Since Fc-7 receptors of phagocytic cells 
could be important for this imaging technique, we 
decided to perform an animal experiment in granulocy­
topenic rats to determine if In-111—IgG showed any 
accumulation in infectious foci while granulocyte counts 
were low. Stimulated by the positive outcome of the 
animal experiment, we studied a group of granulocytope­
nic patients to assess the potential of In-111-IgG scintig­
raphy in localizing focal infection in such patients.
lation was observed in the infectious focus. In the pa­
tients, 13 proven pulmonary, abdominal, joint, and soft 
tissue infections of both bacterial and fungal origin were 
detected adequately, ln -1 11—IgG uptake not due to veri­
fied inflammation was observed in the large bowel of two 
patients. A thoracic wall infiltrate showing only mild 
inflammatory activity was not detected. Small toxoplasmo­
sis lesions in heart, liver, and kidneys were obscured by 
physiologic ln -1 11—IgG activity in these organs.
Conclusions: ln -1 11—IgG scintigraphy is a useful tech­
nique to delineate focal infection in patients with granulo­
cytopenia. Accumulation of the radiopharmaceutical does 
not appear to be granulocyte-mediated, ln -1 11—IgG is a 
safe and convenient radiopharmaceutical that probably 
contributes to the early diagnosis of focal infection in 
granulocytopenic patients.
J Clin Oncol 10:61-68. © 7992 by American Society of 
Clinical Oncology.
MATERIALS AND METHODS
Human nonspecific, polyclonal IgG (Sandoglobulin; Sandoz AG, 
Nuremberg, Germany) was conjugated to diethylenetriaminepen- 
taacetic bicyclic anhydride (bicyclic DTPA) and radiolabeled with 
In-111 (indium chloride; Amersham International Ltd, Bucking­
hamshire, United Kingdom) via citrate t ran sc h e la t io n .T h e  label­
ing efficiency was always higher than 95%.
Imaging Procedures
Scintigraphic images were obtained with a Siemens Orbiter 
gamma camera connected to a Scintiview image processor (Sie­
mens Inc, Hoffman Estates, IL). All images were collected in a 
digital format with a 256 x 256 matrix. A medium-energy, 
parallel-hole collimator was installed. Imaging was performed 
using both In-111 photopeaks (173 keV peak, 15% symmetric 
window; 247 keV peak, 15% symmetric window).
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Anim al Study
In four young, randomly bred, male Wistar rats (weighing 200 to 
220 g), severe granulocytopenia was induced with intrapcritoneally 
injected cyclophosphamide. On days 1, 3, and 6, a dose of 200, 100, 
and 100 mg cyclophosphamide per kg of body weight was injected, 
respectively. The granulocyte count was monitored by daily blood 
samples obtained by orbital puncture. After severe granulocytope­
nia had been established, an infection was induced on day 6 by 
inoculating approximately 10s colony-forming units of Staphylococ­
cus aureus in the left calf muscle. One day later, when gross swelling 
was apparent, 6 mBq of In-111 labeled to 100 fig IgG-DTPA 
conjugate was injected in the tail vein. Scintigraphic images were 
recorded at 4, 24, and 48 hours postinjection (PI). Regions of 
interest with a fixed size were drawn over the infectious focus and 
the contralateral calf muscle. Ratios of In-111—IgG uptake in 
infectious foci to that in the contralateral muscle were calculated. 
All mean values are given ±  SEM.
Patient Study
Patients with fever and a granulocyte count below 2.0 x H f /L  
were eligible for the study. The criteria for fever included an oral 
tem perature  greater than 38.5°C on one occasion or greater than 
38°C on two or more occasions during a 12-hour period, as 
described by the Consensus Panel of the Immunocompromised 
Host Society."1 Antibiotic treatm ent was not stopped or altered 
during the study. The experimental nature of the imaging proce­
dure was explained to the patients. Informed consent was ob­
tained. No patient had a history suggestive of IgA- or IgG- 
deficiency or adverse reaction to previous IgG administration. 
Pregnant and lactating females were excluded from the study. The 
study was approved by the institutional research review board.
Patients received an intravenous (IV) dose of approximately 1 
mg of IgG labeled with 75 mBq of In-111. One patient, a 
15-year-old female, received only 55 mBq of In -111—IgG for 
dosimetric reasons. The effective dose equivalent after IV adminis­
tration of 75 mBq In-111 —IgG was calculated to be 15 mSv and was 
similar to that of leukocyte scintigraphy (18 mSv after IV injection 
of 30 mBq In -111—labeled leukocytes).1112
In -111 —IgG images were obtained at 4, 24, and 48 hours PI for a 
preset time of 5, 7.5, and 10 minutes, respectively. Spot views of the 
total body were obtained at least once 24 hours PI.
Images were interpreted independently by three observers 
blinded to the results of the verification procedures. An In-111- 
IgG scan was in terpreted as positive if focally increasing accumula­
tion of activity could be noted over time.
In -1 11—IgG scintigraphy results were verified by clinical, roen t­
genologic, ultrasonographic, and microbiological methods. All 
mean values are given ± SEM.
RESULTS
Animal Study
On day 6, when calf muscle infection was induced, all 
animals had severe granulocytopenia. The mean granu­
locyte count was 0.1 ± 0.02 x 10‘7L. At all times, 
infectious foci showed a high degree of In -111—IgG
uptake. The ratios of I n - l l l - I g G  uptake in the focus 
relative to that in the noninfected, contralateral muscle 
steadily increased from 2.6 ± 0.3 (4 hours PI) to 6.0 ± 
0.4 (24 hours PI) and finally reached 12.3 ±  1.9 (48 hours 
PI).
Patient Study
Twenty' patients were studied (13 males, seven fe­
males; mean age, 36.9 years; range, 15 to 63 years). 
Sixteen patients suffered from different types of leuke­
mia, three had malignant lymphoma, one had aplastic 
anemia. Most patients were granulocytopenic due to 
remission induction chemotherapy or conditioning regi­
men before bone marrow transplantation. Patient no. 11 
had granulocytopenia of unknown origin. All patients 
were febrile for approximately 1 to 2 weeks.
Individual hemato-oncologic diagnoses, granulocyte 
cell counts, scintigraphic results, and verification proce­
dures are summarized in Table 1. All patients, except 
patients no. 2 and 11, received antibiotic treatment. The 
mean granulocyte count was 0.4 ± 0 . 1  x 104/L; the 
median granulocyte count, 0.2 x 10'VL.
Typical Scintigraphic Findings
After remission reinduction therapy for relapse of 
acute myelogenous leukemia, patient no. 5 developed a 
molar root infection, resulting in an infiltrate in the left 
mandibular region (Fig 1A). This focus was believed to 
be the cause of her fever. Total-body imaging using 
In-111-IgG revealed a large zone with increased uptake 
in the area of the middle lobe of the right lung (Fig IB). 
The chest x-ray, made a few days before scintigraphy, 
was normal (not shown). One week later, only mild 
abnormalities were seen on the chest x-ray (Fig 1C). At 
that time, initial clinical symptoms of pulmonary infec­
tion were noted. A chest x-ray taken 2 weeks after 
scintigraphy showed a hyperdense area, matching the 
area of increased uptake on I n - l l l - I g G  scintigraphy 
(Fig ID). The patient died 1 week later. Postmortem 
examination revealed a pulmonary infection caused by 
Aspergillus famigatus. In this case, In-111—IgG scintigra­
phy showed a pulmonary infection that preceded clinical 
symptoms and chest x-ray abnormalities by at least 1 
week.
Figure 2 shows the images of patient no. 6, who had 
aplastic anemia. Despite antibiotic therapy, he devel­
oped fever and symptoms of pulmonary infection. Scin­
tigraphy showed multiple coin-shaped lesions in both 
lungs (Fig 2A) that matched the lesions on the chest
Table 1. Clinical Characteristics, Granulocyte Counts, Results of ln - 1 1 1 - lg G  Scintigraphy, and Verification Procedures
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Patient
No.
Sex, Age 
(years) Medical History
Granulocytes
( x l0 9/L) IgG Scan Verification
1 M ,3 9 ALL, BMT, GVHD 0.4 Negative Thoracic wall infiltrate after Hickman catheter caused by 
SA.
2 M ,4 5 Hairy cell leukemia 1.0 Negative No infection proven.
3 M ,5 8 B-CLL 0.1 Lungs Pulmonary infection (BAL: SV, SA, HI).
4 M ,5 4 NHL stage IV-B 1.3 Negative No infection (autopsy).
5 F ,43 AML, BMT, relapse AML 0.05 Mandibule
Lungs
Extraction of infected molar tooth.
AF infection of the lung, proven at autopsy.
6 M ,22 Aplastic anemia 0.1 Lungs Clinical and roentgenologic diagnosis: pulmonary As- 
pergillus infection.
7 F,41 AML 0.3 Lungs Pulmonary infection (BAL: CF, HSV)
8 F,1 5 Ileocecal NHL 1.7 Lungs Pulmonary infection (BAL: AF).
9 F,44 AML, BMT, GVHD 0.5 Lungs
Hip
Generalized toxoplasmosis infection (autopsy). 
Sterile femoral head necrosis after prednisone.
10 M,31 Mediastinal NHL, stage l-A 0.6 Thoracic wall Thoracic wall ulcer after diagnostic parasternal mediasti- 
notomy. Pleural effusion: photopenic on IgG; culture: 
no infection.
11 M ,63 CLL 1.0 Right side of lower abdomen Surgery: perforated appendicitis.
12 M ,44 ALL, BMT 0.2 Wrist Septic arthritis with prompt recovery after vancomycin.
13 M, 43 AML 0.2 Colon No infection proven.
14 F,18 Relapse ALL 0.6 Negative No infection; skin lesions (IgG negative): allergic vasculi­
tis.
No infection proven.15 F,1 7 ALL, BMT, GVHD 0.1 Negative
16 F,1 7 AML 0 .06 Right side of lower abdomen Pain and tenderness in the right side of the abdomen, 
disappeared in a few days, no microbiologie confirma­
tion.
17 M ,2 0 ALL 0.1 Negative No infection proven.
18 M ,5 0 AML 0.01 Distal colon No infection proven.
19 M ,3 4 CML 0.03 Lower left side of abdomen  
Oral cavity
Unverified.*
Fulminant oral mucositis.
20 M ,4 0 CML 0 .05 Negative Shoulder (IgG-negative): chloroma.
Abbreviations: BAL, bronchoalveolar lavage; BMT, bone marrow transplant; ALL, acute lymphocytic leukemia; CLL, chronic lymphocytic leukemia; 
NHL, non-Hodgkin's lymphoma; AF, Aspergillus fumigatus; CF, Citrobacter freundii; HI, Haemophilus influenzae; GVHD, graft-versus-host disease; AML, 
acute myelogenous leukemia; CML, chronic myelogenous leukemia; HSV, herpes simplex virus; SA, Staphylococcus aureus; SV, Streptococcus viridans. 
’ This patient died 1 week after scintigraphy. Permission for autopsy was not given.
x-ray (Fig 2B) but were more distinct. The clinical 
course was highly suggestive of an Aspergillus infection. 
Cultural proof could not be obtained despite repeated 
bronchoalveolar lavages. The patient died 1 month after 
scintigraphy due to progressive pulmonary infection. 
Permission for autopsy was not given.
Patient no. 11 with chronic lymphocytic leukemia and 
high fever had no clinical signs of an infectious focus. On 
scintigraphy, however, uptake of In -111-IgG was seen in 
the right side of the lower abdomen (Fig 3). The patient 
developed abdominal pain 1 week later, and a perfo­
rated appendix was surgically removed a few days later.
The scintigraphic results for patient no. 12, a bone 
marrow transplant recipient who developed fever and 
mild swelling of the wrist, depict high I n - l l l - I g G  
uptake in the affected wrist (Fig 4). Puncture did not 
yield specimens for bacterial culture. After vancomycin
had been added to the antibiotic regimen, the patient 
promptly recovered and the inflammation subsided.
Overall Results
Proven Inflammatory and Infectious Foci Showing 
Increased In-111-lgG Uptake (True-Positive Studies)
Pulmonary lesions. Two A  fumigatus infections were 
proven by culture (patients no. 5 and 8). In one patient 
(no. 6) the clinical and roentgenologic course was 
compatible with aspergillosis. Two patients (no. 3 and 7) 
had pulmonary infection caused by bacteria. Patient no. 
9 had a toxoplasmosis infection.
Bone and joint lesions. Septic arthritis showed increas­
ing I n - l l l - I g G  accumulation (patient no. 12). An asep­
tic, prednisone-induced, femoral head necrosis was also 
positive on In-11 1-IgG scintigraphy (patient no. 9).
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A
Fig 1. Patient no. 5. (A) ln -1 11—IgG im age of the head (48 hours PI) showing increased uptake in the left m an d ibu lar region due to m o lar root 
infection (arrow ). (B) Anterior ln -1 1 1 - lg G  im age of the chest (48 hours PI) showing increased uptake in the middle lobe of the right lung (arrow). 
(C) Chest x-ray  1 w eek  after scintigraphy showing only mild abnorm alities in the middle lobe of the right lung. (D) Chest x-ray  2 w eeks after  
scintigraphy showing large hyperdense a rea , matching the a rea  of increased uptake on ln - 1 11—IgG scintigraphy. The patient died in shock 1 
w e e k  later. Postmortem exam ination revealed pulm onary infection caused by Aspergillus fum igatus.  In -1 1 1 —IgG scintigraphy depicted  
pulm onary  infection at least 1 w eek  earlier than the chest x-ray.
Abdominal lesions. An appendicular infiltrate that 
was proven at surgery (patient no. 1 1 ) and an infection 
in the right side of the lower abdomen that was sus­
pected on clinical grounds (patient no. 16) showed 
increased In -111—IgG uptake.
Soft tissue lesions. A mandibular infiltrate due to a 
molar root infection (patient no. 5), a postmediastinot- 
omy thoracic wall ulcer (patient no. 10), and a fulminant 
oral mucositis (patient no. 19) were clearly visualized.
No Infection, Normal In-111-IgG Scintigraphy 
(True-Negative Studies)
A pleural effusion was photopenic on In -111—IgG 
scintigraphy. Repeated cultures remained sterile (pa­
tient no. 10). Skin lesions showed no increased uptake 
and were diagnosed as allergic vasculitis rather than 
septic emboli (patient no. 14). An infectious origin of a 
right shoulder swelling in patient no. 20 could not be 
proven by cultures or roentgenologic examination. At a
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Fig 2. Patient no. 6. (A) A nterior ln - 1 1 1 - lg G  im age of the chest (48 hours PI) showing multiple coin-shaped lesions in both lungs: H, heart; L, 
liver; S, spleen. (B) Chest x -ray  showing abnorm alities that match the lesions on ln - 1 1 1 - lg G  im age, but are  less distinct. The clinical course was  
highly suspect for an Aspergillus  infection.
later date, ehloroma was proven by biopsy, histologic 
examination, and subsequent response to irradiation. In 
five other patients with normal I n - l l l - I g G  scintigra­
phies, infection could not be proven.
Nonin fected Areas With Increased ln -111-IgG  Uptake 
(FaIse-Positive Studies)
In two cases (patients no. 13 and 18) infection could 
not be established. Intense activity was seen in the large 
bowel. In both patients, no clinical or microbiologic 
signs of abdominal infection were present. Patient no. 13 
remained febrile for approximately 2 weeks. During this
Fig 3. Patient no. 11. A nterior ln - 1 11— IgG im age of the abdom en  
(48 hours PI) showing accum ulation in the right side of the lower  
abdom en (arrow ). Approxim ately  2 w eeks after scintigraphy, a perfo ­
rated appendix was rem oved.
Fig 4. Patient no. 12. Im age  of hands and wrists (48 hours PI) 
showing high uptake in left wrist (arrow ). Clinical diagnosis: septic 
arthritis with m arked  clinical im provem ent after antibiotic treatm ent.
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period he was treated with ceftazidime and co-trimox- 
azole. Normalization of temperature coincided with an 
increase of the blood granulocyte count. After treatment 
with ciprofloxacin and co-trimoxazole, patient no. 18 
became afebrile within 2 weeks after scintigraphy.
Proven Focal Infections With No Increased In-111-IgG  
Uptake (False-Negative Studies)
In patient no. 1, a thoracic wall infiltrate caused by S 
aureus showed no increased In-111-IgG uptake. During 
scintigraphy, however, the size of the infiltrate and the 
signs of inflammation had diminished. In the following 
weeks, an extensive P aeruginosa infection of the chest 
wall developed.
For patient no. 9 who had toxoplasmosis, proven 
infection of the heart, kidneys, and liver showed no 
abnormal uptake.
Unassessable Study
In patient no. 19 a focus in the left side of the lower 
abdomen could not be verified. The patient died 1 week 
after scintigraphy. Permission for autopsy was not given.
Calculations for In-111-IgG Scintigraphy
Using the number of evaluated lesions (n = 26) men­
tioned above, we calculated a sensitivity of 76%, a 
specificity of 78%, and an accuracy of 77% for In-111- 
IgG scintigraphy, with a positive predictive value of 87% 
and negative predictive value of 64%.
DISCUSSION
Results from the animal study showed high In-111- 
IgG uptake in the infected muscle. Although the num­
ber of animals was small and only S aureus infection was 
studied, the experiment showed that In-1 11-IgG accumu­
lates in infectious foci, despite low granulocyte counts. 
In rats without granulocytopenia, the ratio of activity 
uptake appeared to be lower (between 2.3 and 3.4).13 
Higher uptake in granulocytopenic rats may be ex­
plained by greater outgrowth of bacteria in the absence 
of granulocytes. We chose S aureus infections for these 
experiments because it is one of the few not rapidly fatal 
infections in granulocytopenic rats. Data in the litera­
ture suggest that the causative microorganism is not a 
determining factor for accumulation of radiolabeled IgG 
in infectious foci, even in immunocompromised ani­
mals. I4'16
Our results in humans indicate that In-111-IgG scin­
tigraphy shows performance characteristics in granulocy­
topenic patients similar to those in patients with normal
or elevated WBC counts.7* Pulmonary, abdominal, joint, 
and soft tissue infections were detected. In patients no. 3 
and 7 with positive In-111-IgG images of the lungs and 
clinical and rocntgcnologic evidence of pulmonary infec­
tion, the possibility must be considered that bronchoalvc- 
olar lavage might have identified resident oral contami­
nation when the bronchoscope was passed through the 
nasopharynx rather than recovering the actual patho­
genic microbial flora. With In-111-IgG, not only bacte­
rial, but also fungal infections were localized adequately 
and sometimes in early stages, as demonstrated by 
patients no. 5 and 11. The diagnosis of infections 
(especially those caused by fungi) in granulocytopenic 
patients is notoriously difficult, and the ability to detect 
such infections holds great promise as it may lead to 
early microbiologic diagnosis and specific treatment. 
Even when microbiologic confirmation is not achieved, 
localization of a focus may give an indication of the 
causative pathogen .17
With regard to our false-positive studies, no infection 
could be proven in two patients showing marked In-111- 
IgG uptake in the large bowel. One reason for this 
accumulation might be significant mucosal barrier dam­
age by cytarabine, given 2 to 3 weeks before imaging. 
This drug is known to cause extensive desquamation of 
the intestinal mucosa with exudation and bleeding. 
Therefore, increased In-111-IgG uptake in the large 
bowel might have been due to increased protein leakage. 
Another possible explanation is that local bowel uptake 
occurred because of a chemotherapy-induced break in 
the mucosal integrity with local bacterial invasion but 
negative blood cultures, and the patient’s temperature 
normalized due to empiric antibiotic treatment.
The number of false-negative studies was low. One 
focal lesion (a thoracic wall infiltrate) was missed. 
Temporary improvement of the infiltrate in the period 
of scintigraphic imaging may have accounted for the 
absence of In-111-IgG accumulation. In a patient with 
generalized toxoplasmosis, the lungs showed increased 
In-111-IgG uptake, whereas the heart, kidneys, and 
liver, containing multiple small lesions, appeared nor­
mal on scintigraphy. This is not surprising, as these 
organs show a relatively high physiologic In-111-IgG 
uptake in all patients, thereby obscuring possible small 
lesions in these organs.
If we assume that In-111-IgG scintigraphy is not 
appropriate for the detection of lesions in organs such as 
the liver, kidneys, and heart because of high background 
activity, it is probably justified to delete the missed 
toxoplasmosis lesions from the calculations. This would
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lead to a sensitivity of 93%, a specificity of 78%, an 
accuracy of 87%, a positive predictive value of 87%, and 
a negative predictive value of 88%.
Until now, all investigations in febrile granulocytope­
nic patients showed low yield. Clinical signs of inflamma­
tion are often lacking.2 Chest x-rays may show a delay 
between the onset of infection and the appearance of 
abnormalities, as demonstrated by patient no. 5.lSA‘} The 
same holds true for ultrasonography and x-ray computed 
tomographic scanning. Surveillance cultures are time 
consuming and costly and have a low predictive value .211'23 
Bronchoalvcolar lavage also has a low yield, especially in 
pulmonary aspergillosis.24
For scintigraphic delineation of infectious foci, sev­
eral techniques are available. However, scarce data are 
reported regarding scintigraphic imaging in granulocyto­
penic patients. The use of gallium-67 (Ga-67) scintigra­
phy in granulocytopenic patients is questionable be­
cause lactoferrin from granulocytes is necessary for 
Ga-67 accumulation, resulting in frequent false-negative 
studies .25*27 Autologous leukocyte scintigraphy is not 
possible, and antihuman granulocyte monoclonal anti­
body scintigraphy seems inappropriate in patients with 
low leukocyte counts. Moreover, the development of 
human antimouse antibodies poses a serious problem 
using the latter technique.2S Several reports document 
the utility of donor leukocyte scintigraphy.2i’3  However, 
preparation of this radiopharmaceutical is complicated, 
time consuming, costly, and it is not free of side effects, 
such as transfusion reactions, HLA-immunization, graft- 
versus-host disease, and the possibility of viral infec­
tion .30'34 On the other hand, In-111-IgG is pathogen-free 
and readily available as a kit. No side effects have been 
seen after the administration of 1 mg dosages of radiola­
beled IgG in more than 350 patients (W.J.G.O., unpub­
lished data, February 1991).7S In addition, the safety of 
intravenous IgG preparations has been established by 
long-term therapeutic administration in gram doses .0
In-111-IgG, like all scintigraphic imaging techniques 
used for detection of focal infection, does not discrimi­
nate between sterile inflammation and focal infection. 
In the present study, this is exemplified by In-111-IgG 
accumulation in a sterile femoral head necrosis.
In one patient, an artifact was observed in the 
subcutaneously tunneled part of the Hickman catheter 
due to injection of In-111-IgG through the catheter. 
Since Hickman catheters are known to be the site and 
source of infection, an optimal scintigraphic image of 
the tissue around the catheter should be obtained. 
Therefore, we recommend administering In-111-IgG 
through direct venipuncture in the contralateral arm.
Despite the use of antibiotics in 18 patients, we 
obtained high-quality images. It seems unnecessary to 
stop or alter antibiotic medication for imaging purposes.
Both the animal and patient studies indicate that 
neutrophils are not a major factor in the uptake of 
In-111-IgG in infectious foci, making Fc-7 receptor- 
mediated accumulation an unlikely mechanism. This is 
in agreement with the hypothesis by Morrel et al,3ft who 
suggest that In-111-IgG accumulation is caused by 
enhanced vascular permeability.
Patients with clinically proven infectious foci repre­
sent a population different from those with no clinically 
identifiable focus (eg, with regard to the recommended 
antibiotic treatment, time course for treatment, and the 
outcome of the febrile episode17). It appears that In-111- 
IgG scintigraphy will become a valuable additional 
diagnostic tool for those febrile patients in whom no 
focus can be identified by conventional techniques or in 
whom an inflammatory component of known abnormali­
ties is to be evaluated. Further studies are needed to 
establish whether In-111-IgG scintigraphy can contrib­
ute to the improvement of therapy in febrile granulocyto­
penic patients due to early localization of focal infection, 
especially in patients with fever of unknown origin who 
do not respond to antibiotic treatment. Furthermore, 
the use of follow-up scans during or after adequate 
treatment of infection warrants further studies .7
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